Myeloma
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Overview of Carfilzomib Treatment in R/R MM
FEATURING
Mehmet Hilmi Dogu
- 3 views
- October 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Immunotherapy Sequencing in MM: Bispecifics Should be Used First
FEATURING
Semra Aydin
- 28 views
- September 25, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Overview of R/R Multiple Myeloma and Data on Carfilzomib
FEATURING
Tulin Tuglular
- 14 views
- September 11, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Treatment Strategies for R/R Multiple Myeloma
FEATURING
Claudio Cerchione
- 24 views
- September 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Sequencing Immunotherapies and CAR-T Application in Multiple Myeloma
FEATURING
Claudio Cerchione
- 32 views
- September 6, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Management of Smoldering Myeloma
FEATURING
Claudio Cerchione
- 60 views
- August 27, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Comprehensive Review of 1L Therapy Approaches in MM
FEATURING
Alpay Yeşilaltay
- 11 views
- August 26, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Treatment of 1L Myeloma in 2024
FEATURING
Ahmad Ibrahim
- 34 views
- August 26, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
A Case of MM With Atypical Cutaneous Presentation Treated With Dara and CyBorD
FEATURING
Bengisu Ece Duman
- 10 views
- August 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Case Discussion: Smoldering MM
FEATURING
Arda Bayar
- 14 views
- August 15, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current Status of Lenalidomide Maintenance in Myeloma
FEATURING
Ant Uzay
- 16 views
- August 15, 2024